CORGENIX MEDICAL CORP/CO 4

4 · CORGENIX MEDICAL CORP/CO · Filed Mar 11, 2015

Form 4

Period: 2015-03-10

Director

Transactions

Disposition to Issuer
"Right to buy'' common stock options
2015-03-10−40,000→ 0 total
Exercise: $0.21From: 2013-08-27Exp: 2020-08-27→ Common Stock (40,000 underlying)
Disposition to Issuer
"Right to buy'' common stock options
2015-03-10−40,000→ 0 total
Exercise: $0.09From: 2011-08-29Exp: 2018-08-29→ Common Stock (40,000 underlying)
Disposition to Issuer
"Right to buy'' common stock options
2015-03-10−40,000→ 0 total
Exercise: $0.10From: 2012-08-27Exp: 2019-08-27→ Common Stock (40,000 underlying)
Disposition to Issuer
"Right to buy'' common stock options
2015-03-10−40,000→ 0 total
Exercise: $0.11From: 2010-09-28Exp: 2017-09-28→ Common Stock (40,000 underlying)

Footnotes (4)

[F1]This option, which has vested in full, was cancelled, pursuant to that certain Agreement and Plan of Merger, dated as of August 27, 2014, by and among Corgenix Medical Corp ("Corgenix"), Centennial Medical Holdings, Inc. ("Centennial") and Centennial Integrated, Inc., a wholly owned subsidiary of Centennial, pursuant to which Corgenix has been acquired by Centennial (the "Merger"), in exchange for a cash payment of $2,200, representing (a) the number of shares underlying the option, multiplied by (b) the excess of $0.27 over the exercise price per share of the option (the "Option Merger Consideration").
[F2]This option, which has vested in full, was cancelled in the Merger in exchange for a cash payment of $6,800, representing the Option Merger Consideration.
[F3]This option, which has vested in full, was cancelled in the Merger in exchange for a cash payment of $7,400, representing the Option Merger Consideration.
[F4]This option, which has vested in full, was cancelled in the Merger in exchange for a cash payment of $6,520, representing the Option Merger Consideration.

Documents

1 file